関連する実験動画

Updated: Sep 9, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K

結腸癌における化学感受剤としてのロスマリン酸:化学抵抗を克服するために核因子-カッパB経路を標的とする

Yun-Yun Xu1, Wen-Jing Chen2, Yu-Jie Cai2

  • 1Department of Obstetrics and Gynecology, Nanchang University, Nanchang 330031, Jiangxi Province, China.

World journal of clinical oncology
|September 3, 2025
PubMed
まとめ

ロスマリン酸 (RA) は,腫瘍の成長を抑制し,薬剤耐性を克服することによって,結腸直腸がん (CRC) に対する二重作用の可能性を示しています. 精密腫瘍学剤としての臨床使用を最適化するためにさらなる研究が必要である.

キーワード:
化学抵抗性化学感受剤大腸がん自然産物核因子-カッパBのシグナリングローズマリン酸

さらに関連する動画

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.4K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K

関連する概念動画

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
259
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K